Teprotumumab for the treatment of thyroid eye disease: The Holy grail, really?

被引：1
|
作者：
Martel, A. [1 ]
机构：
[1] Cote Azur Univ, Univ Hosp Nice, Ophthalmol Dept, 30, voie Romaine, F-06000 Nice, France
来源：
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2023年 / 46卷 / 06期
关键词：
GRAVES ORBITOPATHY; RITUXIMAB;
D O I：
10.1016/j.jfo.2023.01.003
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：567 / 570
页数：4
相关论文
共 50 条
  • [1] Teprotumumab for the treatment of thyroid eye disease
    Ju, Yongjing
    Yang, Junyi
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (08) : 739 - 743
  • [2] Teprotumumab for the treatment of thyroid eye disease
    Fallahi, Poupak
    Ragusa, Francesca
    Paparo, Sabrina Rosaria
    Elia, Giusy
    Balestri, Eugenia
    Mazzi, Valeria
    Patrizio, Armando
    Botrini, Chiara
    Benvenga, Salvatore
    Ferrari, Silvia Martina
    Antonelli, Alessandro
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (02) : 123 - 131
  • [3] Teprotumumab for the Treatment of Active Thyroid Eye Disease
    Douglas, R. S.
    Kahaly, G. J.
    Patel, A.
    Sile, S.
    Thompson, E. H. Z.
    Perdok, R.
    Fleming, J. C.
    Fowler, B. T.
    Marcocci, C.
    Marino, M.
    Antonelli, A.
    Dailey, R.
    Harris, G. J.
    Eckstein, A.
    Schiffman, J.
    Tang, R.
    Nelson, C.
    Salvi, M.
    Wester, S.
    Sherman, J. W.
    Vescio, T.
    Holt, R. J.
    Smith, T. J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (04): : 341 - 352
  • [4] Teprotumumab for the Treatment of Recalcitrant Thyroid Eye Disease
    Men, Clara J.
    Amarikwa, Linus
    Pham, Brandon
    Sears, Connie
    Clauss, Kevin
    Lee, Bradford W.
    Lee, Wendy W.
    Pasol, Joshua
    Ugradar, Shoaib
    Shinder, Roman
    Cockerham, Kimberly
    Wester, Sara
    Douglas, Raymond
    Kossler, Andrea L.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 40 (03): : 276 - 285
  • [5] Perspective on the Current Role of Teprotumumab in Treatment of Thyroid Eye Disease
    Allen, Richard C.
    Bradley, Elizabeth A.
    Fante, Robert G.
    Lucarelli, Mark J.
    OPHTHALMOLOGY, 2021, 128 (08) : 1125 - 1128
  • [6] Impact of Teprotumumab on Clinical Practice in Thyroid Eye Disease
    Rachmasari, Kharisa N.
    Toro-Tobon, David
    Wagner, Lilly H.
    Tooley, Andrea A.
    Bradley, Elizabeth A.
    Stan, Marius N.
    ENDOCRINE PRACTICE, 2024, 30 (10) : 937 - 942
  • [7] Improvement of asymmetric thyroid eye disease with teprotumumab
    Ugradar, Shoaib
    Wang, Yao
    Mester, Tunde
    Kahaly, George J.
    Douglas, Raymond
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2022, 106 (06) : 755 - 759
  • [8] Efficacy and Safety of Teprotumumab in Thyroid Eye Disease
    Teo, Honeylen Maryl
    Smith, Terry J.
    Joseph, Shannon S.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 1219 - 1230
  • [9] Refractory Thyroid Eye Disease Unresponsive to Teprotumumab: A Case Report
    Singh, Gurdeep
    Taylor, Brittany
    Michalek, Samantha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [10] Teprotumumab for Thyroid Eye Disease-related Strabismus
    Dallalzadeh, Liane O.
    Villatoro, George A.
    Chen, Lillian
    Sim, Myung S.
    Movaghar, Mansoor
    Robbins, Shira L.
    Karlin, Justin N.
    Khitri, Monica R.
    Velez, Federico G.
    Korn, Bobby S.
    Demer, Joseph L.
    Rootman, Daniel B.
    Granet, David B.
    Kikkawa, Don O.
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2024, 40 (04): : 434 - 439
12345